Notch signaling in lung cancer.
Notch signaling in lung cancer.
复制标题
DOI:
10.1586/era.10.158
复制
发表时间:
2011-04
影响因子:
3.3
通讯作者:
Bocchetta M
中科院分区:
文献类型:
--
作者:
Galluzzo P;Bocchetta M
Lung cancer is the leading cause of cancer-related deaths in the Western world. Lungs can be affected by a number of histologically diverse malignancies. Nonetheless, the vast majority of lung cancers are classified as non-small cell lung cancer (NSCLC). Despite extensive research on different therapeutic regimens, the overall 5-year survival of patients diagnosed with NSCLC (all stages) is a dismal 15%. Although strongly correlated with tobacco smoke, there is an increasing NSCLC morbidity in individuals who have never smoked. The pattern of genetic lesions found in NSCLC derived from smokers and never-smokers appears to be different. This fact led to the hypothesis that different, still unidentified carcinogens are responsible for lung cancer onset in never-smokers. All the above considerations compel the scientific community to find novel therapeutic targets to fight such a deadly disease. In recent years critical pathways governing embryonic development have been increasingly linked to cancer. Here we will focus on the role of Notch signaling in lung cancer. Notch receptors’ activity can be blocked following different strategies, thus representing a promising alternative/complement to the arsenal of therapeutic strategies currently used to treat lung cancer.
登录
查看更多内容
影响因子:
11.2
作者:
Graziani, Irene;Eliasz, Sandra;Bocchetta, Maurizio
通讯作者:
Bocchetta, Maurizio
影响因子:
8
作者:
Dang, TP;Eichenberger, S;Carbone, DP
通讯作者:
Carbone, DP
影响因子:
3.6
作者:
Chen, Yuqing;Li, Dianming;Wang, Xiaojing
通讯作者:
Wang, Xiaojing
DOI:
10.1152/ajplung.00149.2003
发表时间:
2004-04-01
影响因子:
4.9
作者:
Giangreco, A;Shen, HM;Stripp, BR
通讯作者:
Stripp, BR
影响因子:
64.5
作者:
Kim, CFB;Jackson, EL;Jacks, T
通讯作者:
Jacks, T